Rigel Pharmaceuticals (RIGL) EBT Growth (1y) (2011 - 2026)
Rigel Pharmaceuticals (RIGL) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-79.57% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-313.33% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Rigel Pharmaceuticals |
603.18 Mn |
456.49 Mn |
54.21 Mn |
1.27% |
| Date | Value |
|---|
| Mar 31, 2026 |
1.27% |
| Dec 31, 2025 |
49.22% |
| Sep 30, 2025 |
122.37% |
| Jun 30, 2025 |
5,923.50% |
| Mar 31, 2025 |
239.58% |
| Dec 31, 2024 |
1,965.40% |
| Sep 30, 2024 |
318.22% |
| Jun 30, 2024 |
84.39% |
| Mar 31, 2024 |
39.07% |
| Dec 31, 2023 |
-47.39% |
| Sep 30, 2023 |
70.10% |
| Jun 30, 2023 |
51.08% |
| Mar 31, 2023 |
50.68% |
| Dec 31, 2022 |
106.17% |
| Sep 30, 2022 |
9.73% |
| Jun 30, 2022 |
8.78% |
| Mar 31, 2022 |
-166.50% |
| Dec 31, 2021 |
-18.01% |
| Sep 30, 2021 |
-48.78% |
| Jun 30, 2021 |
15.85% |
